Pharmaffiliates, a leading end-to-end CRDMO services provider in India, will participate in Analitica Brazil 2025, one of the most prominent global events for laboratory technology and analytical innovation.

At this international platform, Pharmaffiliates will highlight its ability to support both small and large molecules as a trusted concept-to-commercial CDMO partner in India. With proven spray dried dispersions CRDMO expertise and scalable manufacturing solutions, the company continues to strengthen its position as a global innovation partner.

Visit : https://www.pharmaffiliates.com/en/analitica-brazil
In biologics, Pharmaffiliates will present advanced offerings such as high-throughput screening CRO services in India, the CHO DG44 platform for biologics manufacturing, and integrated biologics process development services. The company’s biologic early development services in India and monoclonal antibody analytics further underline its capability to deliver precise, regulatory-compliant solutions.

By participating in Analitica Brazil 2025, Pharmaffiliates reaffirms its commitment to empowering research, accelerating development, and building strong collaborations across the pharmaceutical and life sciences sectors.